On May 2, Johnson & Johnson, a pharmaceutical giant, announced that it has invested $1 billion in the acquisition of BeneVir Biopharm, a biotech-company dedicated to oncolytic virus immunotherapy research. This newsRead More…
What Is Immunotherapy？
A 72-year-old Connecticut citizen Bob Carlson was diagnosed with lung cancer four years ago. The doctor estimates that he will not live longer than two years. He tried a variety of programsRead More…
CAR-T: A Constantly Optimized Anti-cancer Therapy
CAR-T cell immunotherapy, the chimeric antigen receptor T-cell immunotherapy, is a highly efficient and advanced cell immunotherapy. The principle is to genetically modify the immune cell T cells in patients to killRead More…
Science: Harvard Discovered Antibody Immunotherapeutics to Help NK Cells Destroy Cancer Cells
There is no doubt that the emergence of immunotherapy has redefined the field of cancer treatment as breakthrough progress. Most immunotherapies now focus on the adaptive immune response, that is, onRead More…
Natrue: Altered Immune Cells Can Eliminate Childhood Brain Tumor in Mice
A study at the Stanford University School of Medicine showed that altered immune cells can eliminate a fatal pediatric brain tumor in a mouse model, which was published in the AprilRead More…
What Are IL-7 & CCL19 CAR-T Cells?
Recently, Japanese scientists have developed a new type of chimeric antigen receptor T cell called 7 × 19 CAR-T cell. This new generation of CAR-T cells target hCD20 antigen and showed aRead More…
Nat Biotechnol: New Generation of CAR-T Can Easily Eliminate Solid Tumors
Huge progress has been made in the CAR-T field recently. Professor Koji Tamada from Yamaguchi University, Department of Immunology, has successfully developed a new generation of CAR-T. Meanwhile, in a variety of solidRead More…
CAR-T Therapy Breakthrough Results Successively Published in Science and Nature
Recently, CAR-T therapy has achieved continuous breakthrough results. First, scientists from the United States and Italy found a better target for CAR-T against a fatal brain tumor. Then, a research team fromRead More…
Oncolytic Virus Significantly Prolong Patients’ Survival in Brain Tumor Treatment
The latest achievement published in Journal of Clinical Oncology showed that a common cold virus could attack deadly brain tumors to prolong patient survival after genetic modification. Researchers from the MD AndersonRead More…
Carl June: The World’s First CAR-T Therapy Released the Latest Data
On February 1, NEJM, the top medical journal, published the results of a pivotal multi-center critical phase 2 trial in support of the “first CAR-T therapy Tisagenlecleucel listed”. The overall survival of patientsRead More…